The Level of Neurogranin in Plasma Exosomes of Patients with Vascular Cognitive Impairment

YUChunlei, SUNWenqiang, TANLin, LIUPing, LIZihao, ZHAOWeina

Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2021, Vol. 4 ›› Issue (1) : 42-45.

PDF(462 KB)
Home Journals Chinese Journal of Alzheimer's Disease and Related Disorders
Chinese Journal of Alzheimer's Disease and Related Disorders

Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders      Editor in chief: Jun WANG

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(462 KB)
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2021, Vol. 4 ›› Issue (1) : 42-45. DOI: 10.3969/j.issn.2096-5516.2021.01.007
Original article

The Level of Neurogranin in Plasma Exosomes of Patients with Vascular Cognitive Impairment

Author information +
History +

Abstract

Objective:

To investigate the expression and significance of neurogranin (NG) in plasma exosomes of patients with vascular cognitive impairment (VCI).

Methods:

Sixty patients with VCI were selected as the observation group, and 40 patients with cerebrovascular disease (CVD) were selected as the observation group. Patients without cognitive impairment were served as CVD group and 30 healthy volunteers as control group. Exosomes were extracted from plasma exosomes kit and verified by electron microscopy and particle size analysis. Ng levels in exosomes were detected by ELISA, and cognitive function (MoCA) score was measured. Mann Whitney U test, t test and Pearson correlation analysis were used for comparison between groups.

Results:

The total MOCA score and scores of attention, language, execution, memory, calculation, orientation and visual structure skills in the observation group were significantly lower than those in the CVD group and the healthy control group (P < 0) The levels of ng in the plasma exosomes of VCI patients, CVD patients and normal controls were (609.89±201.12), (898.28±146.23) and (905.39±130.15) mg/L, respectively. There were significant differences between VCI group and the other two groups (P < 0.05). Conclusion: the level of ng in plasma exosomes of patients with VCI is decreased, which may be a potential diagnostic marker of VCI.

Key words

Vascular Cognitive Impairment / Plasma Exosomes / Neurogranin

Cite this article

Download Citations
YU Chunlei , SUN Wenqiang , TAN Lin , et al . The Level of Neurogranin in Plasma Exosomes of Patients with Vascular Cognitive Impairment[J]. Chinese Journal of Alzheimer's Disease and Related Disorders. 2021, 4(1): 42-45 https://doi.org/10.3969/j.issn.2096-5516.2021.01.007

References

[1]
Bowler JV, Hachinski V. Vascular cognitive impairment: a new approach to vascular dementia[J]. Baillieres Clin Neurol, 1995, 4(2): 357-376.
Jia L, Du Y, Chu L, et al. COAST Group. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12): e661-e671.
[2]
中华医学会神经病学分会痴呆与认知障碍学组写作组. 血管性认知障碍诊治指南[J]. 中华神经科杂志, 2011, 44(2): 142-147.
[3]
Tarawneh R, D’Angelo G, Crimmins D, et al. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease[J]. JAMA Neurol, 2016, 73(5): 561-571.
[4]
Goetzl EJ, Kapogiannis D, Schwartz JB, et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease[J]. FASEB J, 2016, 30(12): 4141-4148.
[5]
李迪, 王文志. 2015年《中国脑血管病一级预防指南》解读[J]. 中国循环杂志, 2015, 30(2): 62-65.
[6]
Portelius E, Zetterberg H, Skillback T, et al. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease[J]. Brain, 2015, 138(11):3373-3385.
[7]
Kvartsberg H, Portelius E, Andreasson U, et al. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls[J]. Alzheimers Res Ther, 2015, 7(1): 40-49.
[8]
Goetzl EJ, Kapogiannis D, Schwartz JB, et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease[J]. FASEB J, 2016, 30(12): 4141-4148.
PDF(462 KB)

Accesses

Citation

Detail

Sections
Recommended

/